Crossref journal-article
Oxford University Press (OUP)
Journal of Antimicrobial Chemotherapy (286)
Bibliography

Escalada, M. G., Harwood, J. L., Maillard, J.-Y., & Ochs, D. (2005). Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 55(6), 879–882.

Authors 4
  1. Margarita Gomez Escalada (first)
  2. J. L. Harwood (additional)
  3. J.-Y. Maillard (additional)
  4. D. Ochs (additional)
References 20 Referenced 65
  1. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature1998; 394: 531–2. (10.1038/28970)
  2. Hoang T, Schweizer HP. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (Fab I): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol1999; 181: 5489–97. (10.1128/JB.181.17.5489-5497.1999)
  3. Heath RJ, Li J, Roland GE et al. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by Triclosan and hexachlorophene. J Biol Chem2000; 275: 4654–9. (10.1074/jbc.275.7.4654)
  4. Slater-Radosti C, Van Aller G, Greenwood R et al. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrob Chemother2001; 48: 1–6. (10.1093/jac/48.1.1)
  5. Heath RJ, Su N, Murphy CK et al. The enoyl-[acyl carrier protein] reductases, FabI and FabL, from Bacillus subtilis. J Biol Chem2000; 275: 40128–33. (10.1074/jbc.M005611200)
  6. Levy CW, Roujeinikova A, Sedelnikova S et al. Molecular basis of triclosan activity. Nature1999; 398: 384–5. (10.1038/18803)
  7. Heath RJ, Rock CO. A triclosan-resistant bacterial enzyme. Nature2000; 406: 145–6. (10.1038/35018162)
  8. McMurry LM, McDermott P, Levy SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for Triclosan. Antimicrob Agents Chemother1999; 43: 711–3. (10.1128/AAC.43.3.711)
  9. Bhat GP, Surolia N. Triclosan and fatty acid biosynthesis in Plasmodium falciparum: New weapon for an old enemy. J Biosci2001; 26: 1–3. (10.1007/BF02708972)
  10. Surolia N, Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl ACP reductase of Plasmodium falciparum. Nat Med2001; 7: 167–73. (10.1038/84612)
  11. McLeod R, Muench SP, Rafferty JB et al. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of Apicomplexan Fab I. Int J Parasitol2001; 31: 109–13. (10.1016/S0020-7519(01)00111-4)
  12. Heath RJ, White SW, Rock CO. Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics. Appl Microbiol Biotechnol2002; 50: 695–703. (10.1007/s00253-001-0918-z)
  13. Liu B, Wang Y, Fillgrove KL et al. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother Pharmacol2002; 49: 187–93. (10.1007/s00280-001-0399-x)
  14. Maillard J.-Y. Bacterial target sites for biocide action. J Appl Microbiol2002; 92: 16S–27S. (10.1046/j.1365-2672.92.5s1.3.x)
  15. Russell AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrob Chemother2003; 52: 750–63. (10.1093/jac/dkg422)
  16. Garbus J, DeLuca HF, Loomans ME et al. The rapid incorporation of phosphate into mitochondrial lipids. J Biol Chem1963; 238: 59–63. (10.1016/S0021-9258(19)83961-3)
  17. Smith KL, Douce R, Harwood JL. Phospholipid metabolism in the brown alga, Fucus serratus. Phytochem1982; 21: 569–73. (10.1016/0031-9422(82)83142-7)
  18. CEN (Comité Européen de Normalisation, European Committee for Standardization). British Standard EN 1499: Chemical Disinfectants and Antiseptics—Hygienic handwash—Test Method and Requirements (phase 2, step 2). CEN, Brussels, 1977.
  19. Maillard J.-Y, Messager S, Veillon R. Antimicrobial efficacy of biocides tested on skin using an ex-vivo test. J Hosp Infect1998; 40: 313–23. (10.1016/S0195-6701(98)90309-7)
  20. Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP. High level triclosan resistance in Pseudomonas aeruginosa is solely due to efflux. Am J Infect Control2003; 31: 124. (10.1067/mic.2003.11)
Dates
Type When
Created 20 years, 4 months ago (April 28, 2005, 8:24 p.m.)
Deposited 4 years, 1 month ago (July 10, 2021, 12:56 a.m.)
Indexed 1 day, 12 hours ago (Aug. 27, 2025, 12:24 p.m.)
Issued 20 years, 4 months ago (April 28, 2005)
Published 20 years, 4 months ago (April 28, 2005)
Published Online 20 years, 4 months ago (April 28, 2005)
Published Print 20 years, 2 months ago (June 1, 2005)
Funders 0

None

@article{Escalada_2005, title={Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa}, volume={55}, ISSN={0305-7453}, url={http://dx.doi.org/10.1093/jac/dki123}, DOI={10.1093/jac/dki123}, number={6}, journal={Journal of Antimicrobial Chemotherapy}, publisher={Oxford University Press (OUP)}, author={Escalada, Margarita Gomez and Harwood, J. L. and Maillard, J.-Y. and Ochs, D.}, year={2005}, month=apr, pages={879–882} }